Last €4.82 EUR
Change Today -0.087 / -1.77%
Volume 0.0
C2CA On Other Exchanges
Symbol
Exchange
Berlin
As of 3:15 PM 12/23/14 All times are local (Market data is delayed by at least 15 minutes).

concord medical - spon adr (C2CA) Snapshot

Open
€4.94
Previous Close
€4.91
Day High
€4.94
Day Low
€4.82
52 Week High
03/6/14 - €6.43
52 Week Low
12/27/13 - €3.04
Market Cap
216.7M
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
44.9M
EX-Date
08/5/14
P/E TM
--
Dividend
--
Dividend Yield
24.89%
Current Stock Chart for CONCORD MEDICAL - SPON ADR (C2CA)

concord medical - spon adr (C2CA) Related Bloomberg News

View More Bloomberg News

concord medical - spon adr (C2CA) Related Businessweek News

View More BusinessWeek News

concord medical - spon adr (C2CA) Details

Concord Medical Services Holdings Limited, through its subsidiaries, operates radiotherapy and diagnostic imaging centers. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy, and diagnostic imaging services. The company also offers other treatments and diagnostic services through the use of medical equipment comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of Parkinson’s disease; and refraction and tonometry for the diagnosis of ophthalmic conditions. In addition, it provides clinical support services, such as developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical research. Further, the company offers radiotherapy and diagnostic equipment leasing and management services to hospitals, as well as is engaged in the sale of medical equipment. The company, through its subsidiaries, holds 52% equity interest in Chang’an Hospital, a non-public general hospital with 1,100 hospital beds located in Xi’an, Shaanxi Province. It also focuses on establishing the Beijing Proton Medical Center that would offer radiotherapy treatment options to cancer patients; and Guangzhou Concord Medical Cancer Hospital, a 400-bed specialty hospital for cancer diagnosis and treatment, as well as other specialty cancer hospitals that would offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of June 30, 2014, it operated a network of 141 centers with 81 hospitals in 56 cities, and 25 provinces and administrative regions in China. The company was founded in 1996 and is headquartered in Beijing, the People’s Republic of China.

608 Employees
Last Reported Date: 04/28/14
Founded in 1996

concord medical - spon adr (C2CA) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

concord medical - spon adr (C2CA) Key Developments

Concord Medical Services Holdings Limited Expects to Open Five Free-Standing Radiotherapy Cancer Centers and to Construct Cancer Hospitals

Concord Medical Services Holdings Limited expects to open five free-standing radiotherapy cancer centers and to begin construction on one to two Level-III premium cancer specialty hospitals in 2015.

Concord Medical Services Holdings Limited Announces Unaudited Consolidated Financial Results for the Third Quarter Ended September 30, 2014

Concord Medical Services Holdings Limited announced unaudited consolidated financial results for the third quarter ended September 30, 2014. Total net revenue was RMB 265.7 million in the third quarter of 2014, a 13.6% increase from RMB 234.0 million in the third quarter of 2013. Net income attributable to ordinary shareholders was RMB 34.5 million, a 30.3% increase from RMB 26.5 million in the third quarter of 2013. Basic and diluted earnings per American Depositary Share were RMB 0.77 and RMB 0.72 respectively, compared with RMB 0.59 in the third quarter of 2013. Adjusted EBITDA (non-GAAP) was RMB 111.4 million, a 9.4% increase from RMB 101.8 million in the third quarter of 2013. Operating income was RMB 56,469,000 compared to RMB 45,431,000 a year ago. Income before income taxes was RMB 53,038,000 compared to RMB 43,910,000 a year ago.

Concord Medical Services Holdings Limited to Report Q3, 2014 Results on Nov 17, 2014

Concord Medical Services Holdings Limited announced that they will report Q3, 2014 results at 5:00 PM, China Standard Time on Nov 17, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
C2CA:GR €4.82 EUR -0.087

C2CA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China Renji Medical Group Ltd/Hong Kong $0.39 HKD +0.02
View Industry Companies
 

Industry Analysis

C2CA

Industry Average

Valuation C2CA Industry Range
Price/Earnings 16.5x
Price/Sales 1.6x
Price/Book 1.0x
Price/Cash Flow 5.9x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CONCORD MEDICAL - SPON ADR, please visit www.cmsholdings.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.